MENU
+Compare
INCR
Stock ticker: NASDAQ
AS OF
Nov 28 closing price
Price
$1.34
Change
-$0.01 (-0.74%)
Capitalization
73.15M

INCR Intercure Ltd Forecast, Technical & Fundamental Analysis

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products... Show more

INCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for INCR with price predictions
Nov 28, 2025

INCR's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for INCR turned positive on November 26, 2025. Looking at past instances where INCR's MACD turned positive, the stock continued to rise in of 40 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where INCR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Bearish Trend Analysis

The 50-day moving average for INCR moved below the 200-day moving average on November 05, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INCR entered a downward trend on November 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.554) is normal, around the industry mean (16.611). P/E Ratio (25.483) is within average values for comparable stocks, (73.365). INCR's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.952). INCR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.900) is also within normal values, averaging (55.743).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. INCR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
INCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

INCR is expected to report earnings to rise 76.67% to 5 cents per share on April 30

Intercure Ltd INCR Stock Earnings Reports
Q4'25
Est.
$0.05
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.01
Q1'24
Beat
by $0.08
The last earnings report on April 07 showed earnings per share of 2 cents, beating the estimate of 0 cents. With 2.32K shares outstanding, the current market capitalization sits at 73.15M.
A.I. Advisor
published General Information

General Information

a provider of outsourced clinical development and commercialization services to biopharmaceutical companies

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
85 Medinat ha-Yehudim Street
Phone
+972 774605012
Employees
370
Web
https://www.intercure.co
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRKR0.250.01
+4.17%
Parkervision, Inc.
MITFY8.48N/A
N/A
Mitie Group Plc.
OQLGF2.30N/A
N/A
Olympique Lyonnais Groupe
PLTYF0.02N/A
N/A
Plastec Technologies, Ltd.
PEXNY7.10-0.20
-2.74%
PTT Exploration & Production Public Co., Ltd.

INCR and Stocks

Correlation & Price change

A.I.dvisor tells us that INCR and CRON have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INCR and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
-0.91%
CRON - INCR
26%
Poorly correlated
-0.40%
SNDL - INCR
25%
Poorly correlated
+1.15%
ACB - INCR
25%
Poorly correlated
+0.22%
TLRY - INCR
24%
Poorly correlated
-21.07%
DVAX - INCR
23%
Poorly correlated
-0.52%
More

Groups containing INCR

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INCR
1D Price
Change %
INCR100%
-0.91%
Pharmaceuticals: Generic
industry (213 stocks)
16%
Poorly correlated
+0.54%